Form 8-K - Current report:
SEC Accession No. 0001513162-19-000221
Filing Date
2019-10-24
Accepted
2019-10-24 16:43:23
Documents
25
Period of Report
2019-10-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 49004
2 EXHIBIT 99.1 exhibit99_1.htm EX-99.1 5541
3 GRAPHIC slide1.jpg GRAPHIC 72516
4 GRAPHIC slide2.jpg GRAPHIC 244233
5 GRAPHIC slide3.jpg GRAPHIC 164548
6 GRAPHIC slide4.jpg GRAPHIC 219388
7 GRAPHIC slide5.jpg GRAPHIC 204085
8 GRAPHIC slide6.jpg GRAPHIC 187686
9 GRAPHIC slide7.jpg GRAPHIC 290287
10 GRAPHIC slide8.jpg GRAPHIC 136847
11 GRAPHIC slide9.jpg GRAPHIC 100994
12 GRAPHIC slide10.jpg GRAPHIC 191006
13 GRAPHIC slide11.jpg GRAPHIC 159883
14 GRAPHIC slide12.jpg GRAPHIC 158707
15 GRAPHIC slide13.jpg GRAPHIC 151706
16 GRAPHIC slide14.jpg GRAPHIC 215527
17 GRAPHIC slide15.jpg GRAPHIC 196356
18 GRAPHIC slide16.jpg GRAPHIC 148960
19 GRAPHIC slide17.jpg GRAPHIC 224979
20 GRAPHIC slide18.jpg GRAPHIC 142716
21 GRAPHIC slide19.jpg GRAPHIC 214357
22 GRAPHIC slide20.jpg GRAPHIC 168456
23 GRAPHIC slide21.jpg GRAPHIC 186615
24 GRAPHIC slide22.jpg GRAPHIC 279212
25 GRAPHIC slide23.jpg GRAPHIC 206599
  Complete submission text file 0001513162-19-000221.txt   5932463
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-37492 | Film No.: 191166599
SIC: 8071 Services-Medical Laboratories